The American Saiojin Group, the University of Southern California, and the Harvard, Yale and Stanford cell genetic scientists, the American Saiojin chief scientist, Professor Qilong.Ying, winner of the Nobel Prize in Science, and the chief scientist Professor Xiaojun.Liu of the University of Edinburgh, and other top R&D doctoral teams have jointly developed the world's first super-targeted immune cell PM-NKT composite cell technology through 20 years of joint research in the group's six major R&D centers around the world.